WebCurie Capital BV is a Dutch early-stage life sciences investor founded in 2024. Its partners Mariette van der Velden-Roesink and Han de Groot have extensive experience in investing,... WebHe is currently CEO of Citryll a company that is developing therapeutic antibodies targeting Neutrophil extracelullar trap (NET) formation and NETs themselves for autoimmune diseases like lupus...
Citryll Closes €18.5M Funding Round - FinSMEs
WebSep 29, 2015 · Mode of Action of Therapeutic Anti-Citrullinated Protein Antibodies Revealed: Inflammation Reduction Due to Inhibition of Netosis WebPaul Peter Tak, MD PhD FMedSci, Professor of Medicine. 2024 PharmaVOICE100 honoree (100 most inspiring people in life sciences). … contoh proker ukm
Helmuth van Es - Chief Executive Officer - Citryll LinkedIn
WebGet Paul Vink's email address (p*****@paulvinkfotografie.nl) and phone number at RocketReach. Get 5 free searches. WebCitryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases. Oss, Noord-Brabant, The Netherlands 1-10 Series B Private citryll.com/ … WebAug 17, 2024 · Citryll – a dutch biotech company – is taking a new approach to treat autoimmune and other human inflammatory diseases like lupus, vasculitis, pulmonary … Citryll was founded by Helmuth van Es, CEO Citryll, Renato Chirivi of ModiQuest … Neutrophils from donors who are completely deficient in MPO do not form NETs, … CIT-013 has a number of life cycle opportunities and after careful analysis … Citryll presents at conferences and aims towards publishing in peer-reviewed … Citryll has a proprietary toolbox to study NET biology and protein citrullination … Citryll’s team consists of seasoned scientists and pharmaceutical … Citryll has gathered some of the best senior people in the industry to join the Board. … Dr. Kaplan is Chief of the Systemic Autoimmunity Branch and Deputy … Citryll’s shareholders are the founders, ModiQuest, Dutch venture capitalists … contoh proker pmr